Frosinone, Italy

Maria Altobelli

This inventor holds 1 USPTO granted patent. Top assignee: Biomedica Foscama Industria Chimico-Farmaceutica. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Altobelli: Innovator in Pharmaceutical Chemistry

Introduction

Maria Altobelli is a distinguished inventor based in Frosinone, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that act as adenosine antagonists. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Maria holds a patent for "Imidazo[1,2-a]quinoxalin-4-amines active as adenosine antagonists." This invention represents a crucial step in the exploration of new therapeutic options for various medical conditions. The patent highlights her ability to create novel compounds that have the potential to impact patient care positively.

Career Highlights

Throughout her career, Maria has been associated with Biomedica Foscama Industria Chimico-Farmaceutica, where she has played a vital role in research and development. Her work has not only contributed to the company's portfolio but has also positioned her as a key figure in the pharmaceutical industry.

Collaborations

Maria has collaborated with notable colleagues, including Stefano Ceccarelli and Sergio Zanarella. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their collective work.

Conclusion

Maria Altobelli's contributions to pharmaceutical chemistry exemplify the spirit of innovation and dedication to improving healthcare. Her patent and collaborations reflect her commitment to advancing medical science and her role as a leading inventor in her field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…